Yunierkis Pérez‐Castillo

Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?

Maykel Cruz‐Monteagudo, José L. Medina‐Franco, Yunierkis Pérez‐Castillo et al. · Drug Discovery Today · 2014 · 187 citations

Activity Cliffs, Medicinal Chemistry, Psychoactive Drug +7

Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors

María João Matos, Carmen Terán, Yunierkis Pérez‐Castillo et al. · Journal of Medicinal Chemistry · 2011 · 165 citations · Full text

HP-Lattice QSAR for dynein proteins: Experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence

María Auxiliadora Dea‐Ayuela, Yunierkis Pérez‐Castillo, Alfredo Meneses‐Marcel et al. · Bioorganic & Medicinal Chemistry · 2008 · 64 citations

Molecular Characterization, Biochemistry, Protein Folding +10

Computational chemistry comparison of stable/nonstable protein mutants classification models based on 3D and topological indices

Humberto González‐Díaz, Yunierkis Pérez‐Castillo, Gianni Podda et al. · Journal of Computational Chemistry · 2007 · 61 citations

Degradation of PET Bottles by an Engineered Ideonella sakaiensis PETase

Maria Eduarda Sevilla, M.D. Garcia, Yunierkis Pérez‐Castillo et al. · Polymers · 2023 · 61 citations · Full text

Engineering, Extensive Plastic Production, Enzymatic Modification +20